Comments
Description
Transcript
Bayer @
02-DEZ-2002 BBYER 19:24 +49 FIG LE’JERKUSEN 214 3055563 s.O1 Bayer @ Bayer AG Pharma Operations/Quality Assurance Integrated Quality Management Kaiser-Wilhelm-Allee 1 Building E 28 5 1368 Leverkusen Germany December 02,2002 Dockets Management Branch (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rochillc, MD 20852 Re: Docket No. OOD- 1539, Draft Guidance for Industry; 21 CFR Part 11; Electronic Records; Electronic Signatures, Maintenance of Electronic Records Bayer appreciates the opportunity to provide comments on the Draft Guidance for Industry: 21 CFR Part 11; Electronic Records; Electronic Signatures, Maintenance of Electronic Records. As a manufacturer of pharmaceuticals, biologicals, medical devices, animal health products, and consumer care products, 2 1 CFR Part I 1 Electronic Records and Electronic Signatures has a significant impact on the Bayer organization. The comments included as in attachment to this letter represent the current thinking of subject matter experts within Bayer. In general, the guidance document as written goes beyond the objective to provide guidance of the Part 11 rule. In some aspects it prescribes a substantial expansion of the scope of Part 11 functional requirements. This expansion does not increase data integrity, product quality or health safety. Maintenance requirements should not impose extraordinary burdens of time, money and technology on the healthcare industry. We recommend revising the guidance document to reflect the original scope of the Part 11 rule. If you have any questions regarding our comments, please contact me. Sincerely, Dr. Erwin Wenning PH-OP-QA-IQMKomputer Tel: 001-2 14-30-35308 Fax: 00 l-2 14-30-50025 / Validation Attachment: Bayer Comments Guidance for Industry: 2 1 CFR Part 11; Electronic Records; Electronic Signatures, Maintenance of Electronic Records Bayer Comments Guidancefor Industry: 21 CFR Part 11; Electronic Records; Electronic Signatures; Maintenance of Electronic Records Draft Guidmw - September 2002 Docket No. OOD-1539 2. Scope Page5 4.1 What does Part 11 require? Page6 4.1WbatdoesPti 11 require? Page8 Document states“...compatible with FDA’s public healthresponsibilities”. This requirement should be changed to “generally equivalent to paper records and handwrittensignaturesexecutedon paper.” Documentstates“Accordingly, the signature manifestationinformation, associatedwith an ekctmnic record that is subject to this requirement, must be maintined f%orthe durationof the recordretentionperiod.“ The requirement shoutd be changed to “Accordingly, the printed name of the signer,the date and time of signing and what the signature means, associated with an electronic record that is subject to this requirement, must be mainhimd for the duration of the record retentionmxiod.” Delete statement“authentic, and compatible with ale FDA’S public health responsibilities.” There is no need to substitutenew wording for the wording in the original rule. It does not confer clarity and introducesnew areas of debateon interpretation. It is heIpfut to specifywhat constitutesthe “siguaturemanifestationinformation” expected. To our understanding the meaning of “euthentic” is equivalent to ‘k~stworthy”. For a guideline the statement“compatible with FDA’s public health responsibilities” does not elevate the understandingof Part 11 requirements. 5.3 ContinuedAvailability Document states“You shoufdperiodically Accessto a representativenumberof records and Readability Of mess a representativenumberof eIectronic to ensurereadabilityis not recommendedfor ElectronicRecord recordsto ensurethat record contentscan the intendedpurpose.This mipfit be an I Bayer Comments Guidance for Industry: 21 CFR Part 11; Electronic Records; Electronic Signatures; Maintenance of Electra& Records Draft Guidance - September2002 Docket No. 0 Information ShouldBe EIWXd Page9 Pages9-10 dill be read and evafuatedthroughoutthe recordsretention period.“ For the intention of tis sectiona physical test of the readabilityof the entire media (e.g. surfncescan)would be more aDDroDfiate. 5.3 ContinuedAvailability At tbe end of the section 5.3 the following and ReadabilityOf sentewe should be added “‘For the purpose of long term retention, electronic records ElectronicRecord Information Should Be may be retained in a format that differs from the orirjnal.” Ensured 5.4 Ehxtronic Records Documentstates‘You shoulddetermine what storageconditions are appropriatefor ShouldBe StoredUnder Appropriate the specificelectronicmedia,and then EnvironmentalConditions maintainthoseconditionsthroughthe record retentionperiod. You shouldmonitor those condkion~... ...suchfactorsa~temperature, humidity, dust, vibration, and sourcesof electromagneticand radiofrequency interference.” ylpropriateapproachafter migration and/or ransformationof recordsin order to verify x validatethe migratio&ansfonnation. It is important to recognize that de-facto datnbatxstandardsand ‘TechnofogyNeutral Formats’offer benefits for the long-term retentionof requiredelectronicrecords. 3itical storagecm&ions are dependenton he type of storagemedia. This requirementshouldbe changedto “You shouldmonitor critical conditionsdepending on the media.Critical conditionscould be temperature,hnmidity, dust,vibration, and 2 Bayer Comments Guidance for Industry: 21 CFR Part 11; Elecinnic Records; Electronic Signatures; Maintenance of Electronic Recorda Draft Guidance - September 2002 electromagneticand radiokquency i5terfereIlce.” Page10 Page11 S-5The Ability To m 4n ElectronicRecord’s informationThroughout ItsRecord5Rele5tion PeriodShouldBe Pnsfxved Ducllme5tstates‘~ughout the records Part 1 I requiresonly the ability to generate retention period, the ability to process information in an efectronic rsGordshould not diminish.” This requiremat should he changed to Throughout the records retention period, electronicrecord should be maintainedin a mmner that allows the electronic record’s infimndon to generatecopiesin hm and computerreadableform that are suitablefor FDA hpection, review, and copying.” 5.5The Ability To Process Documentstates:“Accordingly, where you 4n ElectronicRecord’s could usecomputertechnologiesto search, sort, ur manipulateinformation in an klfolmation Throughout original eledxonicrecord,you shouldbe Its RecordsRetention PeriodShouldBe able to usecomputertechnologiesto Preserved performthe samekind of processingon informationin the maintainedelectronic recurd.” This requirement needsto be deleted accurateand completecopiesin both electronicand humanreadableform. Thereforemaintainingprocesscapability of the old systemis substantialexpansionof scopeuf Part 11 functionalrequirementsthat shouldgo throughthe proper FDA rule making prucessrather than being introduced via guidance. This appliesto the entire section5.5. Typically the accuracyand integrity of the record can be maintained,but the functionality and the featnresof the original applicationsgeneratingthe record are not possibleto maintainunder any reaWc and cost effective archivingapproachavailabfe aY. Part 1I requiresonly the ability to generate accurateand completecopiesin both electronicand humanreadableform. Thereforenniintainingprocesscapability of the old systemis substantialexpansionof 3 Bayer Comments Goidance for Industry: 21 CFR Part 11; Electronic Records; Electronic Signatures; Maintenance of Electronic Records Duff Gnidauce - September 2002 scopeof Part 11 functionalrequirementsthat shouldgo throughthe proper FDA rule makingprocessrather than being introduced via guidance. Page11 5.5 The Ability To Pmcess An Electronic Record’s [nformationThroughclut tts RecoNlsReteution PeriodShouldBe Preserved Document states‘For example,if you could automatidly searchfor words in the text of an etectmnic record, sort or find values in a table, or perform cakulations in a spreadsheet,you should be able to process infctrmation in a hke manner for the electronic record over the entire records retention period. This abiljty (or functionality) derives largely from the hardware and so&are used to extract information horn the electronic record, as well as t&e electronic record format itself. You should include this ability among your specifications in your procedures and controls.” This requirement should be changed to ‘7hroughout the records retention period, elechmic record should be maintained in a manner that allows the electronic record’s information to generatecopiesin human and computerreadableform that are suitable for Mahaining processcapability oTthe old systemis substantialexpansionof scopeof Part 11 functional requirementsthat should go through the proper FDA rule making processrather than being introducedvia guidance. Acceptablealternativesare addressedin the predicaterules. For exampfein the GMPs section211S180 (d) and tie GLPs section 58.195(g), the rule states“Recordsrequired by this part may be retainedeither as original recordsor astrue copiessuch as photocopies,microfihn, microfiche, or other accuratereproductionsof the original records.” This dearly showsthe intent to retain the informationand doesnot require reprocessing.”Requirementfor reprocessing shouldbe limited to thosestatedin a predicaterule and not be introducedthrough Part 11 guidance(s). Bayer Comments Guidance for Industry: 21 CFR Part 11; Electronic Records; Eleclronic Signatures; Matotensnce of EMronic Records Draft Guidauee - September2002 Docket No. OOD-1539 Page12 6.1 The Time Capsule Approach Page14 6.2 The Electronic RecordsMigration Approach PageI8 FDA inspection,review, and copying.” Documentstates‘Throughout the records retentionperiod, you would keep the cmnputer system functional and makeno changesto the computingenvironment.” This requirementshouldbe changedto “Throughoutthe recordsretentionperiod, you would keep the computersystem iimctional.Changescould be necessaryto keeosvsteml-imctionalitv.” Documentstates“However, you should carefuly considerwhen it woufd be prudent to discardthe old electronicrecordsand/or The statement“no changes”is too restrictive. Someminor changesmay be TEcessq for syWnl maintenancewithout compromisingthe tie capsuleapproach. The statementimplies that the old electronic systemwould still be maintainedfor some pfxiod of time a&f3 the electronicrecords SySbXkl...” were migratedto the new system. This requirementwould negatethe benefits of Concernsshouldhe removed datamigration. If properly validata one shouldhave assurancethat the integrity of electronicrecordsis preservedduring and post migratioIl. As audit trails are system-or vendor-specific 6.2.1.3ElectronicRecord Documentstates‘Where a migration, in Integrity Attributes Should effect, createsa new electronicrecord . .. the it might be difficult or even impossibleto audit trail for the migratedelectrunicnxxxd add informationto this original audit trail of Be Preserved would have to cover this creation” a recordwhen migrating the record to a new system.It shouldbe acceptableto maintaiu This requirementshouldhe changedto separatedocumention for ma&nance, “Where an electronicrecord is mimted ... archivingor migrationof the recordsbeside Bayer Comments Guidance for Industry: 21 CFB Part 11; Eleetronk Records; Electronic Signatures; Maintenance of Electronic Records Draft Guidance - September 2002 appropriatedocumentationshouldbe available.” Page19 Page20 the original audit trail. Suchseparate documentationcould be an additionalaudit trail or validationdocumentation. Furthermorea copy of the data is not a human created{or modified) record. A copy of an electronicrecorddoesnot createa “new” recordif the information is the same. 621.4 The Ability To - Documentsfates“In the migration approach, Refer to commentson section5.5. the new compukr systemshould enableyou ProcessInformation In Electronic Records Should to search,soti and processinformationin the migratedelemcmicrecordat leastat the Be Preserved samelevel as what you could attain in the old system.” 6.2.1.5 Unavoidable DifferencesAnd Losses Shouldbe AccountedFor And ExplainedIn The Migraled Electronic RecordOr New System Documentation Page20 6.2.1.5Unavoidable DifferencesAnd Losses Shouldbe AccountedFor This reauirementneedsto be deleted. Documentstatesu Justprior to performing fhe electronicrecordmigration a trusted third party from outsideof the organization that has someresponsibilityfor the electronicrecordverities the digital sign&m using the old systemsmethod.” The requirementof a third party involvementis a substantialexpansionof scopeof Part 11 fktctioniii requirementsthat should go through the proper FDA rule making processrather than being &roduced via guidance. This appliesto all trustedth*d party citationsin this chapter. This requirementneedsto be deleted. Documentgives an examplefor migration of For migration of digital signed electronic digital signedelectronicrecords.This recordsit is neckry to have the complete and accurateinformationabout tbe original chapterneedsto be revised. Bayer Comments Guidance for Industry: 21 CFR Part Xl; Electronic Records; Eiedonic Signatures; Maintenar~e of Electronic Records Draft Guidance - September 2002 hcket No. 01 And Explain&l ht The Migrated Electronic RecordOr New System Documentation Page21 6.2.I.5 Unavoidable DifferencesAnd Losses Shouldbe AccountedFor And ExplainedIn The Migrated Electronic RecordOr New System DDCUmentation Page20 6.2.1.5Unavoidable DifferencesAnd Losses Shouldhe AccountedFor And ExplainedIn The Migrated Electronic RecordOr New System Documentation digital signingavailablea&r migration. V the migratedelectronicrecord is kept in a closedsystema digital signatureis no longer requiredafter migration. rt must be clear &at you are not migrating the signaW itself, but rathermigrating a representationof the fact of the signature. Documentgivesan examplefor migration of color codesand requiresthe creationof an electmnicrecmd to documentthis migration. This exampleshouldbe extendedas follows: “Besidesan electronicrecord other documentationforms e.g. validation documentatiooshouldbe adeoa.” Insert after first sentence of the chapter (“...is preservedand presented.“): ‘“The fundamentalobjective of the migration is to preservethe essentialmeaning of the information asjudged by expertsin the field to be equivaienlto the original in the context of its stated,actualor intendeduse.” Migration to new systems may result in changesin appearanceas well as analytical resultcalculationprecisionfrom the originaf system.Recognizingthis it is imporlau! that the essentiatmeaning of the information not Lhange and that only that information relevant to essential meaning need be migrated 7